We are live on ! Find out more
OP

Omni Partners Portfolio holdings

AUM $2.03B
1-Year Est. Return 126.33%
This Fund
S&P 500
This Quarter Est. Return
+19.37%
1 Year Est. Return
+126.33%
3 Year Est. Return
+411.65%
5 Year Est. Return
+1,549.93%
10 Year Est. Return
AUM
$1.9B
AUM Growth
+$992M
Cap. Flow
+$804M
Cap. Flow %
42.39%
Top 10 Hldgs %
77.34%
Holding
45
New
18
Increased
14
Reduced
Closed
13

Sector Composition

Rank Sector Weight
1 Healthcare 16.52%
2 Technology 14.58%
3 Industrials 14.37%
4 Communication Services 12.03%
5 Consumer Discretionary 5.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APC
1
DELISTED
Anadarko Petroleum
APC
$268M 14.13%
+3,797,692
New +$255M
FDC
2
DELISTED
First Data Corporation
FDC
$267M 14.09%
9,872,681
+3,458,866
+54% +$90M
RHT
3
DELISTED
Red Hat Inc
RHT
$220M 11.59%
1,170,658
+496,817
+74% +$91.7M
CELG
4
DELISTED
Celgene Corp
CELG
$170M 8.98%
1,842,219
+1,242,219
+207% +$118M
MLNX
5
DELISTED
Mellanox Technologies, Ltd.
MLNX
$116M 6.12%
1,049,229
+413,245
+65% +$47.6M
ZAYO
6
DELISTED
Zayo Group Holdings, Inc.
ZAYO
$101M 5.33%
+3,070,990
New +$98M
CZR
7
DELISTED
Caesars Entertainment Corporation
CZR
$86.9M 4.58%
+7,352,585
New +$69.7M
CY
8
DELISTED
Cypress Semiconductor
CY
$83.9M 4.42%
+3,772,900
New +$68.4M
MLNX
9
PUT
DELISTED
Mellanox Technologies, Ltd.
MLNX
$77.5M 4.08%
+7,000
New +$806K
DATA
10
DELISTED
Tableau Software, Inc.
DATA
$76.2M 4.01%
+458,690
New +$60.3M
ARRY
11
DELISTED
Array Biopharma Inc
ARRY
$73.4M 3.87%
+1,585,000
New +$44.5M
WCG
12
DELISTED
Wellcare Health Plans, Inc.
WCG
$60.5M 3.19%
212,267
+192,693
+984% +$53.1M
VSM
13
DELISTED
Versum Materials, Inc.
VSM
$38.5M 2.03%
+746,059
New +$38.5M
AGN
14
DELISTED
Allergan plc
AGN
$36.2M 1.91%
+216,000
New +$29.9M
WP
15
DELISTED
Worldpay, Inc.
WP
$34.4M 1.81%
280,441
+254,138
+966% +$30.1M
MGLN
16
DELISTED
Magellan Health Services, Inc.
MGLN
$33M 1.74%
444,262
+241,671
+119% +$16.2M
SFLY
17
DELISTED
Shutterfly, Inc.
SFLY
$29.5M 1.56%
+583,873
New +$26.7M
GRAF.U
18
DELISTED
Graf Industrial Corp. Units, each consisting of One share of Common Stock and One redeemable Warrant
GRAF.U
$23.5M 1.24%
2,288,144
+228,308
+11% +$2.35M
TRNE.U
19
DELISTED
Trine Acquisition Corp. Units, each consisting of one share of Class A Common Stock and one-half of
TRNE.U
$22.2M 1.17%
2,197,577
+220,312
+11% +$2.22M
WBC
20
DELISTED
WABCO HOLDINGS INC.
WBC
$12M 0.64%
90,837
+17,447
+24% +$2.3M
SAMAU
21
DELISTED
Schultze Special Purpose Acquisition Corp. Unit
SAMAU
$11.1M 0.58%
1,090,193
+115,666
+12% +$1.17M
PVT.U
22
DELISTED
Pivotal Acquisition Corp.
PVT.U
$9.88M 0.52%
851,251
+359,757
+73% +$3.93M
CARS icon
23
Cars.com
CARS
$669M
$8.33M 0.44%
422,485
+128,959
+44% +$2.76M
PACQU
24
DELISTED
Pure Acquisition Corp. Unit
PACQU
$8.04M 0.42%
752,242
+62,630
+9% +$669K
PVT
25
DELISTED
Pivotal Acquisition Corp.
PVT
$7.55M 0.4%
+743,479
New +$7.48M

Similar funds

Omni Partners's Q2 2019 Portfolio in Review

As of Q2 2019, Omni Partners held 45 positions worth $1.9B, up 110% from $904M the previous quarter. Its ten largest holdings account for 77% of the portfolio.

Omni Partners deployed $804M of net new capital in Q2 2019, opening 18 new positions and adding to 14 existing holdings. Its largest new stake was Anadarko Petroleum: 3,797,692 shares worth $268M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 9.9% a quarter earlier, followed by Technology and Industrials.

On the sell side, the most notable exit was TRIBUNE MEDIA COMPANY CLASS A, an estimated $87.9M sold.

  • Omni Partners's largest Q2 2019 buy was Anadarko Petroleum: 3,797,692 shares worth $268M.
  • Omni Partners added most to Celgene Corp in Q2 2019, an estimated $118M increase.
  • Omni Partners fully exited TRIBUNE MEDIA COMPANY CLASS A in Q2 2019, selling an estimated $87.9M.
  • Omni Partners's ten largest holdings make up 77% of its $1.9B portfolio in Q2 2019.
  • Omni Partners opened 18 new positions and closed 13 in Q2 2019.
  • Omni Partners's portfolio value rose 110% quarter-over-quarter to $1.9B.

Based on Omni Partners's 13F filing for Q2 2019, filed 14 Aug 2019.